Delivery Order SPE2DB20D3103-SPE2DB24FL8V8

Award Date 12/12/23
Potential Completion Date 12/13/23
Potential Value $1.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Trulicity 3 mg/0.5 ml pens to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The contract, valued at $1,456.18, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc....
This federal contract award is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The contract, valued at $6,372.27, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves...
This federal contract award is for the delivery of Trulicity 3 mg/0.5 ml pens (0.5 ml) to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $2,612.52, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC...
This federal contract award is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $23,383.56, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 31,...
This federal contract award is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,568.24, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to provide...
This federal contract award is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $1,094.10 contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company that serves as a prime contractor for various federal healthcare programs. The contract is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of Trulicity 3 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $9,039.86 delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor that provides medical supplies and prescription drugs to various government agencies. The contract is a firm-fixed price delivery order placed under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Trulicity 3 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract has a ceiling value of $2,781.65 and an ultimate completion date of October 26, 2022. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of Trulicity 3 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA). The contract, valued at $2,163.84, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FL8V8
    Delivery Order

This federal contract award is for the delivery of Trulicity 3 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The award, valued at $1,451.40, was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 2/27/25, 10:52 AM